Cite
HARVARD Citation
Usmani, N. et al. (2021). Residual meta‐iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. Pediatric blood & cancer. 68 (12), p. n/a. [Online].